Cellution Biologics buys SimpliDerm from Elutia for up to $11M
Tweet Send to a Friend
Cellution Biologics Inc. has completed its acquisition of the SimpliDerm hydrated human acellular dermal matrix business from Elutia Inc. (Nasdaq ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




